General Information of the Compound
Compound ID
CP0256480
Compound Name
2-cyclopropyl-3-(4-fluorophenyl)-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine
    Show/Hide
Structure
Formula
C16H18FN3
Molecular Weight
271.339
Canonical SMILES
Fc1ccc(cc1)-c1c2CCNCCc2nn1C1CC1
    Show/Hide
InChI
InChI=1S/C16H18FN3/c17-12-3-1-11(2-4-12)16-14-7-9-18-10-8-15(14)19-20(16)13-5-6-13/h1-4,13,18H,5-10H2
    Show/Hide
InChIKey
QAVQAAZMSXUAOW-UHFFFAOYSA-N
Physicochemical Property
logP
2.7123
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
29.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11414582
SID: 16510829
ChEMBL ID
CHEMBL4762886
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 100 nM
   TI
   LI
   LO
   TS